Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

The association of nonalcoholic steatohepatitis and hepatocellular carcinoma.

Asfari MM, Talal Sarmini M, Alomari M, Lopez R, Dasarathy S, McCullough AJ.

Eur J Gastroenterol Hepatol. 2020 Feb 18. doi: 10.1097/MEG.0000000000001681. [Epub ahead of print]

PMID:
32073443
2.

Exercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD.

Hari A, Fealy CE, Axelrod CL, Haus JM, Flask CA, McCullough AJ, Kirwan JP.

Med Sci Sports Exerc. 2020 Feb 5. doi: 10.1249/MSS.0000000000002273. [Epub ahead of print]

PMID:
32028458
3.

Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease.

Sandlers Y, Shah RR, Pearce RW, Dasarathy J, McCullough AJ, Dasarathy S.

J Clin Med. 2020 Jan 22;9(2). pii: E314. doi: 10.3390/jcm9020314.

4.

Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease.

Welch N, Dasarathy J, Runkana A, Penumatsa R, Bellar A, Reen J, Rotroff D, McCullough AJ, Dasarathy S.

Liver Int. 2019 Dec 31. doi: 10.1111/liv.14358. [Epub ahead of print]

PMID:
31889396
5.

Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.

Erickson ML, Haus JM, Malin SK, Flask CA, McCullough AJ, Kirwan JP.

Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1197-1204. doi: 10.1016/j.numecd.2019.06.012. Epub 2019 Jun 21.

PMID:
31371265
6.

Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.

Cherla DV, Rodriguez NA, Vangoitsenhoven R, Singh T, Mehta N, McCullough AJ, Brethauer SA, Schauer PR, Aminian A.

Surg Endosc. 2019 Jul 29. doi: 10.1007/s00464-019-07017-0. [Epub ahead of print]

PMID:
31359195
7.

Obstructive Sleep Apnea and the Liver.

Parikh MP, Gupta NM, McCullough AJ.

Clin Liver Dis. 2019 May;23(2):363-382. doi: 10.1016/j.cld.2019.01.001. Review.

PMID:
30947882
8.

Assessing liver fibrosis without biopsy in patients with HCV or NAFLD.

Singh T, Allende DS, McCullough AJ.

Cleve Clin J Med. 2019 Mar;86(3):179-186. doi: 10.3949/ccjm.86a.17118. Review.

9.

Ultrasound-Guided Fine-Needle Aspiration With Optional Core Needle Biopsy of Head and Neck Lymph Nodes and Masses: Comparison of Diagnostic Performance in Treated Squamous Cell Cancer Versus All Other Lesions.

Wagner JM, Monfore N, McCullough AJ, Zhao L, Conrad RD, Krempl GA, Alleman AM.

J Ultrasound Med. 2019 Sep;38(9):2275-2284. doi: 10.1002/jum.14918. Epub 2018 Dec 28.

PMID:
30593702
10.

Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.

Banini BA, Cazanave SC, Yates KP, Asgharpour A, Vincent R, Mirshahi F, Le P, Contos MJ, Tonascia J, Chalasani NP, Kowdley KV, McCullough AJ, Behling CA, Schwimmer JB, Lavine JE, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN).

J Clin Gastroenterol. 2019 Nov/Dec;53(10):750-758. doi: 10.1097/MCG.0000000000001142.

PMID:
30586008
11.

Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis.

Chalasani N, Abdelmalek MF, Loomba R, Kowdley KV, McCullough AJ, Dasarathy S, Neuschwander-Tetri BA, Terrault N, Ferguson B, Shringarpure R, Shapiro D, Sanyal AJ.

Liver Int. 2019 May;39(5):924-932. doi: 10.1111/liv.13974. Epub 2019 Feb 21.

PMID:
30253043
12.

Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis.

Loomba R, Sanyal AJ, Kowdley KV, Terrault N, Chalasani NP, Abdelmalek MF, McCullough AJ, Shringarpure R, Ferguson B, Lee L, Chen J, Liberman A, Shapiro D, Neuschwander-Tetri BA.

Gastroenterology. 2019 Jan;156(1):88-95.e5. doi: 10.1053/j.gastro.2018.09.021. Epub 2018 Sep 15.

13.

Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study.

Hajifathalian K, Torabi Sagvand B, McCullough AJ.

Hepatology. 2019 Aug;70(2):511-521. doi: 10.1002/hep.30226. Epub 2018 Oct 2.

PMID:
30125379
14.

Hepatobiliary and Pancreatic: Mauriac syndrome: A rare cause of elevated liver enzymes.

Khan F, Parikh MP, McCullough AJ.

J Gastroenterol Hepatol. 2019 Feb;34(2):313. doi: 10.1111/jgh.14381. Epub 2018 Aug 16. No abstract available.

PMID:
30112859
15.

Considerations for bariatric surgery in patients with cirrhosis.

Goh GB, Schauer PR, McCullough AJ.

World J Gastroenterol. 2018 Jul 28;24(28):3112-3119. doi: 10.3748/wjg.v24.i28.3112. Review.

16.

Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?

Haskins IN, Chang J, Nor Hanipah Z, Singh T, Mehta N, McCullough AJ, Brethauer SA, Schauer PR, Aminian A.

Surg Obes Relat Dis. 2018 Mar;14(3):342-346. doi: 10.1016/j.soard.2017.11.032. Epub 2017 Dec 8.

PMID:
29519663
17.

Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip.

Saikia P, Roychowdhury S, Bellos D, Pollard KA, McMullen MR, McCullough RL, McCullough AJ, Gholam P, de la Motte C, Nagy LE.

Sci Rep. 2017 Nov 15;7(1):15671. doi: 10.1038/s41598-017-15760-4.

18.

The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.

Lindenmeyer CC, McCullough AJ.

Clin Liver Dis. 2018 Feb;22(1):11-21. doi: 10.1016/j.cld.2017.08.003. Review.

19.

Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease.

Fialho A, Fialho A, Kochhar G, Schenone AL, Thota P, McCullough AJ, Shen B.

Dig Dis Sci. 2018 Feb;63(2):412-421. doi: 10.1007/s10620-017-4828-z. Epub 2017 Nov 6.

PMID:
29110161
20.

Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease.

Cheah MC, McCullough AJ, Goh GB.

J Clin Transl Hepatol. 2017 Sep 28;5(3):261-271. doi: 10.14218/JCTH.2017.00009. Epub 2017 Jun 24. Review.

21.

The association of nonalcoholic steatohepatitis and obstructive sleep apnea.

Asfari MM, Niyazi F, Lopez R, Dasarathy S, McCullough AJ.

Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1380-1384. doi: 10.1097/MEG.0000000000000973.

22.

Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.

Dasarathy J, Varghese R, Feldman A, Khiyami A, McCullough AJ, Dasarathy S.

J Nutr. 2017 Oct;147(10):1938-1946. doi: 10.3945/jn.117.254292. Epub 2017 Aug 16.

23.

The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.

Schugar RC, Shih DM, Warrier M, Helsley RN, Burrows A, Ferguson D, Brown AL, Gromovsky AD, Heine M, Chatterjee A, Li L, Li XS, Wang Z, Willard B, Meng Y, Kim H, Che N, Pan C, Lee RG, Crooke RM, Graham MJ, Morton RE, Langefeld CD, Das SK, Rudel LL, Zein N, McCullough AJ, Dasarathy S, Tang WHW, Erokwu BO, Flask CA, Laakso M, Civelek M, Naga Prasad SV, Heeren J, Lusis AJ, Hazen SL, Brown JM.

Cell Rep. 2017 Jul 5;20(1):279. doi: 10.1016/j.celrep.2017.06.053. No abstract available.

24.

Interobserver Variability in Scoring Liver Biopsies with a Diagnosis of Alcoholic Hepatitis.

Horvath B, Allende D, Xie H, Guirguis J, Jeung J, Lapinski J, Patil D, McCullough AJ, Dasarathy S, Liu X.

Alcohol Clin Exp Res. 2017 Sep;41(9):1568-1573. doi: 10.1111/acer.13438. Epub 2017 Jul 28.

25.

The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.

Schugar RC, Shih DM, Warrier M, Helsley RN, Burrows A, Ferguson D, Brown AL, Gromovsky AD, Heine M, Chatterjee A, Li L, Li XS, Wang Z, Willard B, Meng Y, Kim H, Che N, Pan C, Lee RG, Crooke RM, Graham MJ, Morton RE, Langefeld CD, Das SK, Rudel LL, Zein N, McCullough AJ, Dasarathy S, Tang WHW, Erokwu BO, Flask CA, Laakso M, Civelek M, Naga Prasad SV, Heeren J, Lusis AJ, Hazen SL, Brown JM.

Cell Rep. 2017 Jun 20;19(12):2451-2461. doi: 10.1016/j.celrep.2017.05.077. Erratum in: Cell Rep. 2017 Jul 5;20(1):279.

26.

Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Dasarathy J, McCullough AJ, Dasarathy S.

Alcohol Clin Exp Res. 2017 Aug;41(8):1419-1431. doi: 10.1111/acer.13425. Epub 2017 Jul 11. Review.

27.

Which patients with nonalcoholic fatty liver disease should undergo liver biopsy?

Lindenmeyer CC, McCullough AJ.

Cleve Clin J Med. 2017 Apr;84(4):273-275. doi: 10.3949/ccjm.84a.16029. No abstract available.

28.

Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.

Sourianarayanane A, Arikapudi S, McCullough AJ, Humar A.

Eur J Gastroenterol Hepatol. 2017 Apr;29(4):481-487. doi: 10.1097/MEG.0000000000000820.

PMID:
28253211
29.

Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis.

Sourianarayanane A, Talluri J, Humar A, McCullough AJ.

Eur J Gastroenterol Hepatol. 2017 May;29(5):516-523. doi: 10.1097/MEG.0000000000000825.

PMID:
28079667
30.

Safety and efficacy of bariatric surgery in patients with advanced fibrosis.

Singh T, Kochhar GS, Goh GB, Schauer P, Brethauer S, Kroh M, Aminian A, Lopez R, Dasarathy S, McCullough AJ.

Int J Obes (Lond). 2017 Mar;41(3):443-449. doi: 10.1038/ijo.2016.212. Epub 2016 Nov 24.

PMID:
27881858
31.

Anthony S. Tavill, M.D., F.A.C.P., F.R.C.P., F.A.C.G. (1936-2016).

McCullough AJ.

Hepatology. 2017 Feb;65(2):756-759. doi: 10.1002/hep.28892. Epub 2016 Dec 19. No abstract available.

PMID:
27786362
32.

Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD.

Li L, Bebek G, Previs SF, Smith JD, Sadygov RG, McCullough AJ, Willard B, Kasumov T.

J Proteome Res. 2016 Sep 2;15(9):3388-404. doi: 10.1021/acs.jproteome.6b00601. Epub 2016 Aug 5.

33.

Acute Alcoholic Hepatitis, the Clinical Aspects.

Dugum MF, McCullough AJ.

Clin Liver Dis. 2016 Aug;20(3):499-508. doi: 10.1016/j.cld.2016.02.008. Epub 2016 May 14. Review.

34.

Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease.

Fialho A, Fialho A, Thota P, McCullough AJ, Shen B.

J Gastrointestin Liver Dis. 2016 Jun;25(2):159-65. doi: 10.15403/jgld.2014.1121.252.iwg.

35.

Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.

Kochhar G, Singh T, Dust H, Lopez R, McCullough AJ, Liu X, Fung J, Shen B.

Inflamm Bowel Dis. 2016 Jul;22(7):1670-8. doi: 10.1097/MIB.0000000000000830.

PMID:
27306073
36.

Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease.

Kullman EL, Kelly KR, Haus JM, Fealy CE, Scelsi AR, Pagadala MR, Flask CA, McCullough AJ, Kirwan JP.

J Appl Physiol (1985). 2016 May 15;120(10):1159-64. doi: 10.1152/japplphysiol.00693.2015. Epub 2016 Mar 31.

37.

Natural History of Nonalcoholic Fatty Liver Disease.

Goh GB, McCullough AJ.

Dig Dis Sci. 2016 May;61(5):1226-33. doi: 10.1007/s10620-016-4095-4. Epub 2016 Mar 22. Review.

PMID:
27003142
38.

Pregnancy outcomes and reproductive health after liver transplantation.

Lindenmeyer CC, McCullough AJ.

Clin Liver Dis (Hoboken). 2016 Jan 21;6(6):142-144. doi: 10.1002/cld.518. eCollection 2015 Dec. Review. No abstract available.

39.

Reply re: "Proprioceptive Phenomenon With Involutional Ptosis: Evidential Findings in Anophthalmic Ptosis".

Segal KL, Lelli GJ Jr, Djougarian A, Rosenberg CR, McCullough AJ, Lisman RD.

Ophthalmic Plast Reconstr Surg. 2016 Jan-Feb;32(1):69. doi: 10.1097/IOP.0000000000000596. No abstract available.

PMID:
26735957
40.

Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.

Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai RK, Dasarathy S, McCullough AJ.

BBA Clin. 2014 Sep 20;3:141-5. doi: 10.1016/j.bbacli.2014.09.001. eCollection 2015 Jun.

41.

The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

Goh GB, Issa D, Lopez R, Dasarathy S, Dasarathy J, Sargent R, Hawkins C, Pai RK, Yerian L, Khiyami A, Pagadala MR, Sourianarayanane A, Alkhouri N, McCullough AJ.

J Gastroenterol Hepatol. 2016 May;31(5):995-1000. doi: 10.1111/jgh.13235.

PMID:
26589761
42.

In Response.

Dasarathy S, Dasarathy J, Khiyami A, Yerian L, McCullough AJ.

J Clin Gastroenterol. 2016 Feb;50(2):181. doi: 10.1097/MCG.0000000000000451. No abstract available.

PMID:
26583270
43.

Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States.

Guirguis J, Chhatwal J, Dasarathy J, Rivas J, McMichael D, Nagy LE, McCullough AJ, Dasarathy S.

Alcohol Clin Exp Res. 2015 Nov;39(11):2085-94. doi: 10.1111/acer.12887. Epub 2015 Oct 25. Review.

44.

Proprioceptive Phenomenon With Involutional Ptosis: Evidential Findings in Anophthalmic Ptosis.

Segal KL, Lelli GJ Jr, Djougarian A, Rosenberg CR, McCullough AJ, Lisman RD.

Ophthalmic Plast Reconstr Surg. 2016 Mar-Apr;32(2):113-5. doi: 10.1097/IOP.0000000000000438.

PMID:
25794025
45.

Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.

Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Pai RK, Yerian L, Khiyami A, Sourianarayanane A, Sargent R, Hawkins C, Dasarathy S, McCullough AJ.

Dig Dis Sci. 2015 Jun;60(6):1825-31. doi: 10.1007/s10620-015-3529-8. Epub 2015 Feb 24.

PMID:
25708897
46.

FSMB issues model telemedicine policy.

Welch SS, McCullough AJ.

J Med Assoc Ga. 2014;103(3):24, 26. No abstract available.

PMID:
25665346
47.

Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis.

Tsien C, Davuluri G, Singh D, Allawy A, Ten Have GA, Thapaliya S, Schulze JM, Barnes D, McCullough AJ, Engelen MP, Deutz NE, Dasarathy S.

Hepatology. 2015 Jun;61(6):2018-29. doi: 10.1002/hep.27717. Epub 2015 Feb 27.

48.

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop.

Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L; American Association for the Study of Liver Diseases; United States Food and Drug Administration.

Hepatology. 2015 Apr;61(4):1392-405. doi: 10.1002/hep.27678. Epub 2015 Mar 19.

49.

Impact of transjugular intrahepatic portosystemic shunt on post-colectomy complications in patients with ulcerative colitis and primary sclerosing cholangitis.

Kochhar G, Navaneethan U, Parungao JM, Hartman J, Gupta R, Lopez R, McCullough AJ, Kapoor B, Shen B.

Gastroenterol Rep (Oxf). 2015 Aug;3(3):228-33. doi: 10.1093/gastro/gou085. Epub 2014 Dec 16.

50.

Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease.

Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough AJ, Dasarathy S.

Liver Int. 2015 Mar;35(3):979-85. doi: 10.1111/liv.12611. Epub 2014 Jul 5.

PMID:
24905085

Supplemental Content

Loading ...
Support Center